Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Pittcon 2012 Releases Conference Summary

Published: Thursday, March 29, 2012
Last Updated: Thursday, March 29, 2012
Bookmark and Share
The Pittcon 2012 Organizing Committee announced that this year's conference and exposition for laboratory science attracted 15,754 attendees (conferees and exhibitor personnel) to the annual event.

The event, which was held in Orlando, Florida, March 11-15 also attracted twenty-nine percent of the conferees from 89 countries outside the United States.

Pittcon 2012 President Jon Peace commented, "In a time where economic changes, increased mergers and acquisitions, and rising travel costs have a substantial impact on conferences, attendees still consider Pittcon to be a most valuable educational and networking resource for the global scientific community."

The Exposition included 948 exhibiting companies occupying 1,854 booths showcasing their latest laboratory instrumentation, equipment and services across a broad range of applications and technologies used in laboratory science. There were 191 exhibiting companies (20%) from 28 countries outside of the United States. This year, Pittcon welcomed 119 (12.5%) first time exhibitors and recognized the following returning companies that participated at Sponsorship Level: ABSCIEX, Jasco, Millipore, Sigma-Aldrich, Shimadzu, and Thermo Fisher Scientific.

The comprehensive Technical Program included more than 2,000 individual presentations distributed among Invited Symposia, Organized Contributed Sessions, Achievement Awards, Workshops, and Poster presentations. More than 100 invited speakers addressed topics of global interest, including alternative and sustainable energy, homeland security, food and drug safety, environmental issues, new materials development, and bioanalytical techniques. Approximately 1,400 people attended the Plenary Lecture presented by R. Graham Cooks, and Steven Benner delivered the Capstone Lecture to an audience of 700.

The 2012 Short Course program offered 95 courses (16 of which were new) and drew approximately 1,400 registrants which was a 16% increase over 2011 attendance.

The Pittcon Employment Bureau registered 143 employers, 512 candidates, 444 positions, and 455 interviews for the week.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,900+ scientific posters on ePosters
  • More than 4,200+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Pittcon Announces Recipients of the Editors’ Awards
Recipients include Texas Instruments (Gold), Waters (Silver) and ABSciex (Bronze).
Thursday, April 10, 2014
Scientific News
Envigo Rat Models Proven to be Susceptible to Intra-Vaginal HSV-2 Infection and Protectable
Scientific findings establish the effectiveness of new approach to investigate the protective effects of vaccine candidates and anti-viral microbodies and to study asymptomatic primary genital HSV-2 infection.
Drug that Activates Innate Immune System Identified
Researchers from the institute have identified a drug, which is straightforward to synthesize and to couple to antigens that induce an immune response and may prove useful in the generation of vaccines.
Valvena, GSK Sign New R&D Collaboration
Valneva to supply process development services for EB66® -based Influenza vaccines.
Counting Cancer-busting Oxygen Molecules
Researchers from the Centre for Nanoscale BioPhotonics (CNBP), an Australian Research Centre of Excellence, have shown that nanoparticles used in combination with X-rays, are a viable method for killing cancer cells deep within the living body.
Therapeutic Approach Gives Hope for Multiple Myeloma
A new therapeutic approach tested by a team from Maisonneuve-Rosemont Hospital (CIUSSS-EST, Montreal) and the University of Montreal gives promising results for the treatment of multiple myeloma, a cancer of the bone marrow currently considered incurable with conventional chemotherapy and for which the average life expectancy is about 6 or 7 years.
Protein Protects Against Flu in Mice
The engineered molecule doesn’t provoke inflammation and may hail a new class of antivirals.
Crowdfunding the Fight Against Cancer
From budding social causes to groundbreaking businesses to the next big band, crowdfunding has helped connect countless worthy projects with like-minded people willing to support their efforts, even in small ways. But could crowdfunding help fight cancer?
Natural Protein Points to New Inflammation Treatment
Findings may offer insight to effective treatments for inflammatory diseases, such as rheumatoid arthritis, psoriasis, and multiple sclerosis.
Tricked-Out Immune Cells Could Attack Cancer
New cell-engineering technique may lead to precision immunotherapies.
Therapy Halts Progression of Lou Gehrig’s Disease
Researchers at Oregon State University announced today that they have essentially stopped the progression of amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease, for nearly two years in one type of mouse model used to study the disease – allowing the mice to approach their normal lifespan.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,900+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,200+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!